Flonase Nasal Spray
Company: GlaxoSmithKline
Approval Status: Approved November 1997
Treatment for: allergic rhinitis
Areas: Immunology/Infectious Diseases; Pulmonary/Respiratory Diseases
General Information
Other Useful Resources
Flonase nasal spray has been approved by the FDA for the treatment of seasonal and perennial allergic rhintis in children four years and older. This supplementary new dosage application represents an extension of the product to include younger children.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
